Latest Commercialisation News

Aurora Labs has partnered with Sovereign Propulsion Systems to advance testing and commercialisation of its novel turbine engines for defence applications, marking a significant step in UAV propulsion innovation.

Aurora Labs has secured over A$900,000 in contracts with the Australian Defence Force, pushing forward its advanced propulsion systems and additive manufacturing capabilities. A strategic partnership with Sovereign Propulsion Systems aims to integrate these innovations into next-generation unmanned aerial systems.

Aurora Labs has raised $5.5 million through a strategic placement, partnering with Sovereign Propulsion Systems to advance its drone propulsion technology and expand manufacturing capabilities.

Zeotech Limited has signed a non-binding MOU with Cement Australia to collaborate on advancing AusPozz™, a high-reactivity metakaolin product aimed at reducing carbon emissions in concrete production.

Altech Batteries has raised $6 million through a share placement to accelerate development and commercialisation of its innovative battery technologies, including the CERENERGY solid-state battery and Silumina Anodes.

ReNerve Limited has achieved its first commercial sales of the EmpliQ™ amniotic tissue products, marking a significant step in its transition from R&D to commercialisation. The EmpliQ™ range complements its existing nerve repair solutions and targets a growing global wound care market.

Ionic Rare Earths has raised $15.6 million through a heavily oversubscribed rights issue and placement, anchored by a $3 million strategic investment from U.S.-based Argentem Creek Partners. The capital will fund the company’s global expansion in magnet recycling and rare earth supply chain development amid rising geopolitical tensions.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

INOVIQ Limited has raised $11.5 million through a $9.5 million placement and a $2 million share purchase plan to accelerate the development and commercialisation of its EXO-OC ovarian cancer test and exosome therapeutic program.

ClearVue Technologies has raised A$4.6 million in a strongly supported placement to accelerate international certification and ongoing innovation of its solar façade products.

ABx Group reports outstanding impurity removal results from bulk sample tests at its Deep Leads rare earth project, retaining over 98% of critical rare earths and advancing towards a mixed rare earth carbonate product sample in late 2025.

Constellation Resources has confirmed the presence of natural hydrogen and helium in its Edmund-Collier project through CSIRO testing, marking a pioneering step in Western Australia's energy exploration landscape.